We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Ms
Abrar
Babateen
Age-related impairment of cognitive function and cerebral blood flow, cerebral hypo-perfusion
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Nitric oxide (NO) is a small molecule produced in the body which is involved in the control of several functions such as blood pressure (BP), blood clotting, energy metabolism and inflammation. NO is also involved in enhancing cognitive function, which usually declines as we age and with increased body weight. This can happen by increasing blood flow to the brain. This study will ask participants to drink beetroot juice, which contains NO. We will then investigate whether ingestion of beetroot for three months would increase the concentrations of NO in the body and understand the effects on cognitive function and cerebral blood flow in overweight and obese participants.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2020 Results article in https://www.ncbi.nlm.nih.gov/pubmed/32405570 results (added 15/05/2020)2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33653009/ (added 18/01/2023)2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35268027/ (added 18/01/2023)
You can take part if:
You may not be able to take part if:
1. Current participation in other research clinical studies 2. Systolic blood pressure lower than 115 mmHg and greater than 160 mmHg3. Diastolic BP lower than 70 mmHg and greater than 100 mmHg 4. Active cancer and any diagnosis of malignant cancer in the last 5 years5. Excessive alcohol intake6. Allergy or intolerance to the intervention food7. Diagnosis of chronic and acute metabolic and inflammatory conditions interfering with the study outcome, including flu, Crohn’s disease, rheumatoid arthritis and epilepsy8. Major surgical operations interfering with the study outcomes9. Taking any of the following if the dose has been started/changed in the previous 3 months: 9.1. Hormonal therapies (oestrogens, thyroxin, and progesterone)9.2. Anti-hypertensive drugs (Ca++ channel blockers, beta-blockers, and angiotensin-converting-enzyme (ACE) inhibitors)9.3. Statins 9.4. Any other anti-dyslipidaemic agent9.5. Psychiatric drugs (antidepressants, sedatives, antipsychotics)Non-prescribed vitamin or other dietary supplements will be stopped during the study.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Ms
Abrar
Babateen
The study is sponsored by Royal Embassy of Saudi Arabia Cultural Bureau and funded by Saudi Arabia Cultural Bureau in London.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
You can print or share the study information with your GP/healthcare provider or contact the research team directly.